Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (5y) (2020 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.93% |
| Dec 31, 2025 | 2.03% |
| Sep 30, 2025 | 5.60% |
| Jun 30, 2025 | 1.98% |
| Mar 31, 2025 | 3.20% |
| Dec 31, 2024 | -0.17% |
| Sep 30, 2024 | -2.65% |
| Jun 30, 2024 | -16.05% |
| Mar 31, 2024 | 10.63% |
| Dec 31, 2023 | -12.49% |
| Sep 30, 2023 | -8.71% |
| Jun 30, 2023 | -11.54% |
| Mar 31, 2023 | -24.70% |
| Dec 31, 2022 | -23.60% |
| Sep 30, 2022 | -26.85% |
| Jun 30, 2022 | -27.94% |
| Mar 31, 2022 | -32.18% |
| Dec 31, 2021 | -22.96% |
| Sep 30, 2021 | -60.41% |
| Jun 30, 2021 | -34.85% |